Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-11-17 00:00:00 ET · period of report 2021-11-15 · accession 0001708138-21-000086 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-17 | 2021-11-16 | REGN | MURPHY ANDREW J | EVP Research | S - Sale+OE | $647.17 | -7,167 | 61.5K | -10% | -$4.64M |
| D | 2021-11-17 | 2021-11-15 | REGN | MURPHY ANDREW J | EVP Research | F - Tax | $641.50 | -9,412 | 62.9K | -13% | -$6.04M |
| D | 2021-11-17 | 2021-11-15 | REGN | MURPHY ANDREW J | EVP Research | M - OptEx | $52.03 | +16.6K | 72.3K | +30% | +$862.6K |
| D | 2021-11-17 | 2021-08-16 | REGN | MURPHY ANDREW J | EVP Research | G - Gift | $0.00 | -1,645 | 55.7K | -3% | $0 |
| D | 2021-11-17 | 2021-11-15 | REGN | MURPHY ANDREW J | EVP Research | M - OptEx | $0.00 | -16.6K | 16.5K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-16 | S | D | 465 | $642.76 | 62,407 | D | — | — | (F2) Represents volume-weighted average price of sales of 465 shares of Company stock on November 16, 2021 at prices ranging from $642.35 to $642.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. |
| 2 | Common | Common Stock | 2021-11-16 | S | D | 557 | $646.52 | 58,180 | D | — | — | (F6) Represents volume-weighted average price of sales of 557 shares of Company stock on November 16, 2021 at prices ranging from $646.12 to $646.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. |
| 3 | Common | Common Stock | 2021-11-16 | S | D | 844 | $647.39 | 57,336 | D | — | — | (F7) Represents volume-weighted average price of sales of 844 shares of Company stock on November 16, 2021 at prices ranging from $647.09 to $647.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. |
| 4 | Common | Common Stock | 2021-11-16 | S | D | 86 | $648.20 | 57,250 | D | — | — | (F8) Represents volume-weighted average price of sales of 86 shares of Company stock on November 16, 2021 at prices ranging from $648.15 to $648.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. |
| 5 | Common | Common Stock | 2021-11-16 | S | D | 5 | $649.26 | 57,245 | D | — | — | |
| 6 | Common | Common Stock | 2021-11-16 | S | D | 296 | $651.42 | 56,949 | D | — | — | (F9) Represents volume-weighted average price of sales of 296 shares of Company stock on November 16, 2021 at prices ranging from $651.00 to $651.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. |
| 7 | Common | Common Stock | 2021-11-16 | S | D | 133 | $652.24 | 56,816 | D | — | — | (F10) Represents volume-weighted average price of sales of 133 shares of Company stock on November 16, 2021 at prices ranging from $652.22 to $652.40. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. |
| 8 | Common | Common Stock | 2021-11-16 | S | D | 454 | $653.31 | 56,362 | D | — | — | (F11) Represents volume-weighted average price of sales of 454 shares of Company stock on November 16, 2021 at prices ranging from $653.04 to $653.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. |
| 9 | Common | Common Stock | 2021-11-16 | S | D | 198 | $654.34 | 56,164 | D | — | — | (F12) Represents volume-weighted average price of sales of 198 shares of Company stock on November 16, 2021 at prices ranging from $654.07 to $654.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. |
| 10 | Common | Common Stock | 2021-11-16 | S | D | 92 | $655.30 | 56,072 | D | — | — | (F13) Represents volume-weighted average price of sales of 92 shares of Company stock on November 16, 2021 at prices ranging from $655.20 to $655.31. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. |
| 11 | Common | Common Stock | 2021-11-16 | S | D | 74 | $657.46 | 55,998 | D | — | — | |
| 12 | Common | Common Stock | 2021-11-16 | S | D | 71 | $658.56 | 55,927 | D | — | — | |
| 13 | Common | Common Stock | 2021-11-16 | S | D | 155 | $659.15 | 55,772 | D | — | — | (F14) Represents volume-weighted average price of sales of 155 shares of Company stock on November 16, 2021 at prices ranging from $659.01 to $659.30. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. |
| 14 | Common | Common Stock | 2021-11-16 | S | D | 67 | $660.32 | 55,705 | D | — | — | |
| 15 | Common | Common Stock | 2021-11-16 | S | D | 1,106 | $644.71 | 60,377 | D | — | — | (F4) Represents volume-weighted average price of sales of 1,106 shares of Company stock on November 16, 2021 at prices ranging from $644.24 to $644.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. |
| 16 | Common | Common Stock | 2021-11-16 | S | D | 1,640 | $645.41 | 58,737 | D | — | — | (F5) Represents volume-weighted average price of sales of 1,640 shares of Company stock on November 16, 2021 at prices ranging from $645.01 to $645.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. |
| 17 | Common | Common Stock | 2021-11-15 | F | D | 9,412 | $641.50 | 62,872 | D | — | — | |
| 18 | Common | Common Stock | 2021-11-15 | M | A | 16,579 | $52.03 | 72,284 | D | — | — | |
| 19 | Common | Common Stock | 2021-11-16 | S | D | 924 | $643.42 | 61,483 | D | — | — | (F3) Represents volume-weighted average price of sales of 924 shares of Company stock on November 16, 2021 at prices ranging from $643.07 to $643.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price. |
| 20 | Common | Common Stock | 2021-08-16 | G | D | 1,645 | $0.00 | 55,705 | D | — | — | |
| 21 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-11-15 | M | D | 16,579 | $0.00 | 16,500 | D | $52.03 · — to 2021-12-16 | 16,579 Common Stock | (F15) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |